NovoCure
NVCR
NVCR
355 hedge funds and large institutions have $12.9B invested in NovoCure in 2020 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 119 increasing their positions, 88 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
26% more funds holding
Funds holding: 282 → 355 (+73)
0.44% more ownership
Funds ownership: 72.47% → 72.9% (+0.44%)
11% less funds holding in top 10
Funds holding in top 10: 9 → 8 (-1)
Holders
355
Holding in Top 10
8
Calls
$352M
Puts
$215M
Top Buyers
| 1 | +$193M | |
| 2 | +$135M | |
| 3 | +$70.8M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$48.3M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
+$46.5M |
Top Sellers
| 1 | -$118M | |
| 2 | -$99.5M | |
| 3 | -$84.9M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$80.7M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$56.9M |